• Thursday, October 17, 2024

News

4.3
Bitcoin Surges to 18-Month Highs, Signaling a Bull Market
News

Bitcoin Surges to 18-Month Highs, Signaling a Bull Market

Bitcoin and other cryptocurrencies reach fresh 18-month highs, signaling the start of a new bull market. Traders are bullish, technical market conditi...

4.4
Brookfield Corp. Reports Drop in Earnings for Q3
News

Brookfield Corp. Reports Drop in Earnings for Q3

Brookfield Corp. records a drop in earnings and net income in Q3, but predicts strong future growth with increasing cash flows and improved business e...

4.4
Apple's Tax Spat Takes Another Turn: EU Advisor Recommends Nullifying Legal Victory
News

Apple's Tax Spat Takes Another Turn: EU Advisor Recommends Nullifying Legal Victory

An advisor to the European Court of Justice recommends nullifying Apple's legal victory in a tax dispute, raising uncertainties for the company and ke...

5.0
Gaza City Under Attack
News

Gaza City Under Attack

Israeli strikes relentlessly pound Gaza City, causing destruction and displacement. Negotiations for a possible cease-fire and international aid effor...

4.9
China's Economy Faces Deflationary Pressure
News

China's Economy Faces Deflationary Pressure

China's economy faces deflationary pressure as consumer prices decline, affecting the recovery from the Covid-19 pandemic. Although not traditional de...

4.8
U.S. Stock Futures Mixed as Bond Yields Remain Low
News

U.S. Stock Futures Mixed as Bond Yields Remain Low

U.S. stock futures show mixed trend as bond yields remain low. Traders await comments from Fed Chair Jerome Powell for further insight. Stocks are str...

4.3
STV Group Expects Decline in Full-Year Operating Profit
News

STV Group Expects Decline in Full-Year Operating Profit

STV Group predicts a decline in operating profit for 2023, primarily attributed to slump in national TV advertising. Revenue growth of over 30% was ac...

4.6
AstraZeneca Strikes Exclusive Licensing Deal with Eccogene for ECC5004
News

AstraZeneca Strikes Exclusive Licensing Deal with Eccogene for ECC5004

AstraZeneca has signed an exclusive licensing agreement with Eccogene for ECC5004, a potential treatment for type-2 diabetes and obesity. The deal inc...

4.6
Rivian Automotive Inc. Faces Challenges Despite Better-Than-Expected Quarter
News

Rivian Automotive Inc. Faces Challenges Despite Better-Than-Expected Quarter

Rivian Automotive Inc. faces challenges despite a better-than-expected quarter, including scaling challenges, cash burn, and investor skepticism.

4.6
Canadian Stocks Slightly Lower as Sector Performance Remains Mixed
News

Canadian Stocks Slightly Lower as Sector Performance Remains Mixed

The Canadian stock market experiences mixed sector performance, with gains in consumer discretionary and tech services but losses in energy and materi...